US Stock MarketDetailed Quotes

AVTX Avalo Therapeutics

Watchlist
  • 15.9400
  • +0.9600+6.41%
Close Apr 26 16:00 ET
  • 16.0000
  • +0.0600+0.38%
Post 19:57 ET
16.48MMarket Cap-139P/E (TTM)

Avalo Therapeutics Key Stats

Avalo Therapeutics Earnings Date

Currency: USD

Period

Q4 FY2023 Earnings

--

Revenue(YoY)

571.00K

-36.27%
EPS(YoY)

-10.19

+95.92%

Buy

Apr 16, 2024

Avalo Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q2-- / 0.000--
--2024/Q1-- / 0.000--
--2023/Q4571.000K / 300.000K--
--2023/Q3236.000K / 1.000M--
--2023/Q2643.000K / 500.000K--
--2023/Q1475.000K / 1.000M--
--2022/Q4896.000K / 3.611M--
--2022/Q314.949M / 1.258M--
--2022/Q21.033M / 743.250K--
--2022/Q11.173M / 516.400K--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q2-- / 0.000--
--2024/Q1-- / 0.000--
--2023/Q4571.000K / 300.000K--
--2023/Q3236.000K / 1.000M--
--2023/Q2643.000K / 500.000K--
--2023/Q1475.000K / 1.000M--
--2022/Q4896.000K / 3.611M--
--2022/Q314.949M / 1.258M--
--2022/Q21.033M / 743.250K--
--2022/Q11.173M / 516.400K--

Unlock Free Earnings Estimates

Avalo Therapeutics Earnings Reports

Read more

Analysis

Analyst Rating

Updated: Apr 16, 2024

Buy

  • Buy

    100.00%
  • Hold

    0.00%
  • Sell

    0.00%

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg